nanoMR, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

nanoMR, Inc. - overview

Location

Albuquerque, NM, US

Primary Industry

Biotechnology

About

nanoMR, Inc. specializes in innovative molecular diagnostics, focusing on pathogen detection technologies that enhance healthcare outcomes through rapid and accurate results. nanoMR, Inc. is engaged in the development of pathogen detection systems, establishing a significant presence in Albuquerque, US.


The company was acquired by DNA Electronics in January 2015 for USD 24 mn, marking a strategic pivot to integrate its Pathogen Capture System with DNAe Ltd. 's technology. The founder's details are currently unavailable. Currently, the domain nanomr.


com is for sale, offered by HugeDomains. The service focuses on domain name registration, allowing businesses to secure digital assets that enhance their online presence. HugeDomains offers payment options including one-time purchases and installment plans targeting entrepreneurs and established companies seeking to strengthen their digital footprint. HugeDomains generates revenue through the sale of domain names, with pricing starting at USD 595 and monthly payment options available for approximately USD 16.


53 over 36 months. They conduct transactions directly with clients, providing a 30-day money-back guarantee to enhance customer confidence in their purchases. Following the acquisition in January 2015, the integration of nanoMR’s Pathogen Capture System with DNA Electronics' technology aims to create a comprehensive blood-to-result solution. Future growth initiatives may include the expansion into additional diagnostic markets, although specific markets and dates have not been disclosed.


The funding from the recent Trade Sale will be utilized to support these strategic developments.


Current Investors

Signal Peak Ventures, Dow Venture Capital, Sun Mountain Capital

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy

Website

www.nanomr.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.